Showing results (1691-1700 of 1,782) with videos related to

Sort By:
Pageof 179
Breast Cancer Research : BCR|August 9, 2023
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestryPooja Middha, Xiaoliang Wang, Sabine Behrens, et al.
Breast Cancer Research : BCR|December 29, 2024
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk predictionKristia Yiangou, Nasim Mavaddat, Joe Dennis, et al.
American Journal of Human Genetics|June 16, 2015
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionHatef Darabi, Karen McCue, Jonathan Beesley, et al.
Plos Genetics|April 2, 2013
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskMia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, et al.
International Journal of Epidemiology|December 13, 2017
Body mass index and breast cancer survival: a Mendelian randomization analysisQi Guo, Stephen Burgess, Constance Turman, et al.
Plos One|July 7, 2012
Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Tomas Kirchhoff, Mia M Gaudet, Antonis C Antoniou, et al.
Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association ConsortiumHelen Warren, Frank Dudbridge, Olivia Fletcher, et al.
International Journal of Cancer|April 19, 2016
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancerJiajun Shi, Yanfeng Zhang, Wei Zheng, et al.
Journal of Medical Genetics|February 28, 2016
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testingDouglas F Easton, Fabienne Lesueur, Brennan Decker, et al.
Pageof 179